Skip to content

Virgin Coconut Oil Versus Chlorhexidine Mouthwash in Non-Surgical Periodontal Therapy of Periodontitis Patients. A Randomized Controlled Clinical Trial With Biochemical Assessment.

Virgin Coconut Oil Versus Chlorhexidine Mouthwash in Non-Surgical Periodontal Therapy of Periodontitis Patients. A Randomized Controlled Clinical Trial With Biochemical Assessment.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07706387
Enrollment
42
Registered
2026-07-15
Start date
2026-07-01
Completion date
2026-08-01
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage II Periodontitis

Keywords

Stage II periodontitis, virgin coconut oil mouthwash, TNF-alpha, Chlorhexidine mouthwash, Non-surgical periodontal therapy

Brief summary

This randomized controlled clinical trial will evaluate the effect of virgin coconut oil mouthwash compared with chlorhexidine mouthwash as an adjunct to non-surgical periodontal therapy in patients with stage II periodontitis. Participants will receive scaling and root planing, followed by the assigned mouthwash for 30 days. Clinical periodontal parameters, including plaque index, gingival index, bleeding on probing, probing pocket depth, and clinical attachment level, will be recorded. Gingival crevicular fluid samples will also be collected to assess tumor necrosis factor-alpha levels before and after mouthwash use. The study aims to compare the clinical and biochemical effects of the two mouthwashes.

Interventions

PROCEDURENon-surgical periodontal therapy

Full-mouth supra- and subgingival scaling and root planing will be performed as part of phase I periodontal therapy.

OTHERChlorhexidine mouthwash

Chlorhexidine mouthwash will be used as an adjunct to non-surgical periodontal therapy according to the assigned treatment protocol.

OTHERVirgin coconut oil mouthwash

Virgin coconut oil mouthwash will be used as an adjunct to non-surgical periodontal therapy according to the assigned treatment protocol.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

TNF-alpha assessment will be performed by blinded laboratory personnel using coded GCF samples. Participants and investigators will not be masked.

Eligibility

Sex/Gender
ALL
Age
30 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 1\. Both genders. 2. Age (30-50) years old. 3. Systemically free according to the modified Burkett's health history questionnaire . 4\. Generalized Periodontitis Stage II . 5. Having at least 20 tooth excluding wisdoms. 6. No history of dental visit in past three months. 7. Participants willing to commit for the entire period of the trial and agreed to sign the written consent after full explanation of the study.

Exclusion criteria

* 1\. Smokers. 2. Status of Pregnancy or Contraceptives usage. 3. Allergy to coconut oil . 4. Previous Periodontal treatment within the last 6 months. 5. Antibiotic and/or Anti-inflammatory therapy within the last 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Clinical attachment level(CAL)From baseline (48 hours after non-surgical periodontal therapy) to 4 weeks after mouthwash use.Clinical attachment level (CAL) will be measured in millimeters from the cementoenamel junction to the base of the periodontal pocket using a manual Michigan O periodontal probe with Williams markings. Measurements will be recorded at six sites per tooth for all teeth, excluding third molars. The mean CAL value will be calculated and recorded for each patient.
Periodontal pocket depth(PPD)From baseline (48 hours after non-surgical periodontal therapy) to 4 weeks after mouthwash usePeriodontal pocket depth (PPD) will be measured in millimeters from the gingival margin to the base of the periodontal pocket using a manual Michigan O periodontal probe with Williams markings. Measurements will be recorded at six sites per tooth for all teeth, excluding third molars. The mean PPD value will be calculated and recorded for each patient.
Plaque Index(PI)From baseline (48 hours after non-surgical periodontal therapy) to 4 weeks after mouthwash usePlaque index (PI) will be assessed on the buccal and lingual surfaces of all teeth using a standardized 0-3 clinical scoring system. The mean PI score will be calculated and recorded for each patient. Surfaces with PI scores of 1, 2, or 3 will also be considered plaque-positive, and the percentage of plaque-positive surfaces will be calculated.
Gingival index(GI)From baseline (48 hours after non-surgical periodontal therapy) to 4 weeks after mouthwash useGingival index (GI) will be assessed on the buccal and lingual surfaces of all teeth using a standardized 0-3 clinical scoring system. The mean GI score will be calculated and recorded for each patient. Surfaces with GI scores of 1, 2, or 3 will also be considered inflammation-positive, and the percentage of inflammation-positive surfaces will be calculated.
Sulcus bleeding index (SBI)From baseline (48 hours after non-surgical periodontal therapy) to 4 weeks after mouthwash useSulcus bleeding index (SBI) will be assessed after gentle probing of the gingival sulcus using a standardized 0-3 clinical scoring system. The mean SBI score will be calculated and recorded for each patient. Sites with SBI scores of 1, 2, or 3 will also be considered bleeding-positive, and the percentage of bleeding-positive sites will be calculated.

Secondary

MeasureTime frameDescription
Change in gingival crevicular fluid TNF-alpha levelFrom baseline (48 hours after non-surgical periodontal therapy) to 4 weeks after mouthwash useTumor necrosis factor-alpha (TNF-alpha) level will be measured in gingival crevicular fluid (GCF) samples collected using sterile perio paper strips. Samples will be analyzed using enzyme-linked immunosorbent assay (ELISA), and TNF-alpha concentration will be recorded for each patient.
Patient satisfaction regarding mouthwash-related side effectsAt 4 weeks after mouthwash use.Patient satisfaction regarding mouthwash-related side effects will be assessed using a patient questionnaire and clinical inspection after mouthwash use. The assessment will include taste alteration, tooth staining, supragingival calculus accumulation, and overall satisfaction with mouthwash use. Responses and clinical findings will be recorded and summarized for each patient

Countries

Egypt

Contacts

CONTACTWASIM JOUMA ALHAYEK, B.D.S.
doctor.wasem.94@gmail.com+201023828515
CONTACTYasmine El-Sayed Fouad, Ass.Lecture
+201005793929
STUDY_DIRECTORAhmed Amr, Professor

Faculty of dentistry-Ain Shams University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026